Virtual 2021

Browse: Pre-Congress Content Sunday, 05.09.2021 Monday, 06.09.2021 Tuesday, 07.09.2021 Wednesday, 08.09.2021		View the presentations you missed during Congress! More than 1'200 webcasts and slide presentations, 2'300 e-posters and , 3'000 abstracts from the Virtual Congress 2021 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2021; 58: Suppl. 65, abstract number.

Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists

Symposium
Chairs: T. Blum (Berlin, Germany), M. Wijsenbeek (Rotterdam, Netherlands)
Aims: to provide an overview of the epidemiology, clinical, radiological and pathological characteristics and prognosis of patients with lung cancer (LC) associated with fibrotic interstitial lung disease (fILD); to describe evidence of pathophysiological intersections between these two diseases and the importance of designing new therapeutic strategies based on this knowledge; to explain the importance of cancer treatments that could improve the survival of such patients; to investigate how anti-fibrotic treatments or other therapeutic innovations could modify the natural history of these diseases.

Download all media

Current portrait of LC-fILD: from epidemiology to clinico-patholo-radiological presentation and prognosis M. Funke-Chambour (Bern, Switzerland)
Pathophysiology of LC and fILD : siblings or just friends? V. Poletti (Forlì, Italy)
How to stop LC-fILD progression: an overview of modern therapeutic strategies J. Cadranel (Paris Cedex 20, France)
How to disrupt malicious LC-fILD pathways: antifibrotic agents as a promising therapeutic approach A. Wells (London, United Kingdom)
Discussion and Q&A